3628 Stock Overview
Provides medical information services in Japan. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Data Horizon Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥399.00 |
52 Week High | JP¥949.00 |
52 Week Low | JP¥353.00 |
Beta | 0.95 |
11 Month Change | 6.12% |
3 Month Change | -30.85% |
1 Year Change | -52.73% |
33 Year Change | -79.76% |
5 Year Change | -57.10% |
Change since IPO | 42.50% |
Recent News & Updates
Shareholder Returns
3628 | JP Healthcare Services | JP Market | |
---|---|---|---|
7D | -2.0% | 1.6% | -0.4% |
1Y | -52.7% | -31.1% | 11.4% |
Return vs Industry: 3628 underperformed the JP Healthcare Services industry which returned -31.1% over the past year.
Return vs Market: 3628 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
3628 volatility | |
---|---|
3628 Average Weekly Movement | 10.4% |
Healthcare Services Industry Average Movement | 5.9% |
Market Average Movement | 3.8% |
10% most volatile stocks in JP Market | 7.6% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 3628's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 3628's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 374 | Yoshio Utsumi | www.dhorizon.co.jp |
Data Horizon Co.,Ltd. provides medical information services in Japan. The company offers data health related services to insurers; and generic drug notification services, as well as analytics for data health planning, medical examinations, diabetic nephropathy and hypertension aggravation, and behavior and medical institution consultation services.
Data Horizon Co.,Ltd. Fundamentals Summary
3628 fundamental statistics | |
---|---|
Market cap | JP¥5.06b |
Earnings (TTM) | -JP¥902.00m |
Revenue (TTM) | JP¥4.91b |
1.0x
P/S Ratio-5.6x
P/E RatioIs 3628 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
3628 income statement (TTM) | |
---|---|
Revenue | JP¥4.91b |
Cost of Revenue | JP¥3.54b |
Gross Profit | JP¥1.37b |
Other Expenses | JP¥2.27b |
Earnings | -JP¥902.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -71.16 |
Gross Margin | 27.88% |
Net Profit Margin | -18.37% |
Debt/Equity Ratio | 112.1% |
How did 3628 perform over the long term?
See historical performance and comparison